M. Tamada

CD44s regulates the TGF-β-mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma.

H. Saya, O. Nagano, H. Baba, 2012, Cancer research.

Hepatocellular Carcinoma and Is Associated with Poor Prognosis in Patients with Mediated Mesenchymal Phenotype − β CD 44 s Regulates the TGF-Updated

H. Saya, O. Nagano, H. Baba, 2012 .

Tumor and Stem Cell Biology CD 44 s Regulates the TGF-b – Mediated Mesenchymal Phenotype and Is Associatedwith Poor Prognosis in Patients with Hepatocellular Carcinoma

H. Saya, O. Nagano, H. Baba, 2012 .

Hochuekkito (TJ-41), a Kampo Formula, Ameliorates Cachexia Induced by Colon 26 Adenocarcinoma in Mice

Momoko Yoshikawa, Kazuhisa Takahashi, F. Takahashi, 2012, Evidence-based complementary and alternative medicine : eCAM.

Pyruvate Kinase M2: Multiple Faces for Conferring Benefits on Cancer Cells

M. Suematsu, H. Saya, M. Tamada, 2012, Clinical Cancer Research.

CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth.

M. Ohmura, T. Masuko, M. Suematsu, 2011, Cancer cell.

Modulation of glucose metabolism by CD44 contributes to antioxidant status and drug resistance in cancer cells.

M. Ohmura, N. Onishi, M. Suematsu, 2012, Cancer research.

ESR, ENDOR, and ESEEM investigations on UV-irradiated 2,4,6-tri-tert-butyl phenol crystals

A. Katayama, J. Yamauchi, M. Tamada, 2000 .

Impacts of CD44 knockdown in cancer cells on tumor and host metabolic systems revealed by quantitative imaging mass spectrometry.

K. Tsuchihashi, M. Ohmura, M. Suematsu, 2015, Nitric oxide : biology and chemistry.